DC Chemicals

All products / DC10444

Sapacitabine (CYC682)
CAT. NO. DC10444

Sapacitabine (CYC682)

Pack sizes and prices

Pack sizePrice
100 mg$800 USDRequest a quote →
250 mg$1,500 USDRequest a quote →
1 g$2,600 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Sapacitabine is unique in that it is an orally available nucleoside analog prodrug of CNDAC that acts through a dual mechanism. As a prodrug, it exhibits the therapeutic effect upon being metabolized; CNDAC lasts longer in the bloodstream by being metabolized from sapacitibine than by being directly administered. The compound interferes with DNA synthesis by causing single-strand DNA breaks due to CNDAC being incorporated into DNA during replication or repair,then inducing arrest of the cell division cycle at G2 phase.oth sapacitabine and its major metabolite, CNDAC, have demonstrated potent anti-tumor activity in both blood and solid tumors in preclinical studies. In a liver metastatic mouse model, sapacitabine was shown to be superior to gemcitabine (Gemzar; Lilly) or 5-FU, two widely used nucleoside analogs, in delaying the onset and growth of liver metastasis.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC10444
Product nameSapacitabine (CYC682)
CAS151823-14-2
Molecular formulaC26H42N4O5
Molecular weight490.63
Purity>98%
SMILESCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)C#N

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Sapacitabine (CYC682) (DC10444)

Related research products